David Patton

Center for Biomedical Informatics and Information Technology National Cancer Institute

关注

立即认领

关注

立即认领

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 72 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Phase II Study of Ulixertinib in Children and Young Adults with Tumors Harboring Activating Mitogen-Activated Protein Kinase Pathway Alterations: APEC1621J of the National Cancer Institute-Children's Oncology Group Pediatric MATCH Trial

Kieuhoa T. Vo,Amit J. Sabnis,P. Mickey Williams,Sinchita Roy-Chowdhuri,David R. Patton,Brent Coffey,Joel M. Reid,Jin Piao,Lauren Saguilig,Todd A. Alonzo,Stacey L. Berg,Alok Jaju,Elizabeth Fox,Brenda J. Weigel,Douglas S. Hawkins,Margaret M. Mooney,Naoko Takebe,James V. Tricoli,Katherine A. Janeway,Nita L. Seibel,D. Williams Parsons

JCO PRECISION ONCOLOGY (2024)

引用0浏览0WOS引用

Phase II Study of Erdafitinib in Patients with Tumors with Fibroblast Growth Factor Receptor Mutations or Fusions: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2

Jun Gong,Alain C. Mita,Zihan Wei,Heather H. Cheng,Edith P. Mitchell,John J. Wright,S. Percy Ivy,Victoria Wang, Robert C. Gray,Lisa M. Mcshane,Larry V. Rubinstein,David R. Patton,P. Mickey Williams,Stanley R. Hamilton,James V. Tricoli,Barbara A. Conley,Carlos L. Arteaga,Lyndsay N. Harris,Peter J. O'Dwyer,Alice P. Chen,Keith T. Flaherty

JCO PRECISION ONCOLOGY (2024)

引用0浏览0WOS引用

Phase II Study of Samotolisib in Children and Young Adults with Tumors Harboring Phosphoinositide 3-Kinase/mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D

Theodore W Laetsch,Kathleen Ludwig,P Mickey Williams,Sinchita Roy-Chowdhuri,David R Patton,Brent Coffey,Joel M Reid,Jin Piao,Lauren Saguilig,Todd A Alonzo,Stacey L Berg,Joyce Mhlanga,Elizabeth Fox,Brenda J Weigel,Douglas S Hawkins,Margaret M Mooney,Naoko Takebe,James V Tricoli,Katherine A Janeway,Nita L Seibel,Donald Williams Parsons

JCO precision oncology (2024): e2400258-e2400258

引用0浏览0WOS引用

Phase II Study of Osimertinib in Patients with Epidermal Growth Factor Receptor Mutations: Results from the NCI-MATCH ECOG-ACRIN (EAY131) Trial Subprotocol E

Monica F. Chen,Zihe Song,Helena A. Yu,Lecia V. Sequist,Christine M. Lovly,Edith P. Mitchell,Jeffrey A. Moscow,Robert J. Gray,Victoria Wang,Lisa M. McShane,Larry V. Rubinstein,David R. Patton,P. Mickey Williams,Stanley R. Hamilton,Yoshie Umemura,James V. Tricoli,Barbara A. Conley,Carlos L. Arteaga,Lyndsay N. Harris,Peter J. O'Dwyer,Alice P. Chen,Keith T. Flaherty

JCO PRECISION ONCOLOGY（2024）

引用0浏览0WOS引用

Olaparib for Childhood Tumors Harboring Defects in DNA Damage Repair Genes: Arm H of the NCI-COG Pediatric MATCH Trial

Julia L. Glade Bender,Kerice Pinkney,Paul M. Williams,Sinchita Roy-Chowdhuri,David R. Patton,Brent D. Coffey, Joel M. Reid,Jin Piao,Lauren Saguilig,Todd A. Alonzo,Stacey L. Berg,Nilsa C. Ramirez,Elizabeth Fox,Brenda J. Weigel,Douglas S. Hawkins,Margaret M. Mooney,Naoko Takebe,James Tricoli,Katherine A. Janeway,Nita L. Seibel,Donald W. Parsons

ONCOLOGIST (2024)

引用0浏览0WOS引用

Phase II Study of Vemurafenib in Children and Young Adults with Tumors Harboring BRAF V600 Mutations: NCI-COG Pediatric MATCH Trial (APEC1621) Arm G

Marie Nelson,Aerang Kim,P. Mickey Williams,Sinchita Roy-Chowdhuri,David R. Patton,Brent D. Coffey,Joel M. Reid,Jin Piao,Lauren Saguilig,Todd A. Alonzo,Stacey L. Berg,Nilsa C. Ramirez,Alok Jaju,Elizabeth Fox,Brenda J. Weigel,Douglas S. Hawkins,Margaret M. Mooney,Naoko Takebe,James Tricoli,Katherine A. Janeway,Nita L. Seibel,D. Williams Parsons

The Oncologist (2024)

引用0浏览0WOS引用

Palbociclib in Solid Tumor Patients with Genomic Alterations in the Cyclind-Cdk4/6-ink4a-rb Pathway: Results from National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I)

Margaret E Macy,Rajen Mody, Joel M Reid,Jin Piao,Lauren Saguilig,Todd A Alonzo,Stacey L Berg,Elizabeth Fox,Brenda J Weigel,Douglas S Hawkins,Margaret M Mooney,P Mickey Williams,David R Patton,Brent D Coffey,Sinchita Roy-Chowdhuri,Naoko Takebe,James V Tricoli,Katherine A Janeway,Nita L Seibel,D Williams Parsons

JCO precision oncology (2024): e2400418-e2400418

引用0浏览0WOS引用

Supplementary Figures 1 from Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI–MATCH ECOG–ACRIN Trial (EAY131) Subprotocol J

Roisin M. Connolly,Victoria Wang,David M. Hyman,Petros Grivas,Edith P. Mitchell,John J. Wright,Elad Sharon,Robert J. Gray,Lisa M. McShane,Larry V. Rubinstein,David R. Patton,P. Mickey Williams,Stanley R. Hamilton,Jue Wang,Kari B. Wisinski,James V. Tricoli,Barbara A. Conley,Lyndsay N. Harris,Carlos L. Arteaga,Peter J. O'Dwyer,Alice P. Chen,Keith T. Flaherty

crossref（2024）

引用0浏览0引用

Supplementary tables 1 from Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal <i>HER2</i>-Amplified Tumors: Results from the NCI–MATCH ECOG–ACRIN Trial (EAY131) Subprotocol J

crossref（2024）

引用0浏览0引用

Trastuzumab and Pertuzumab in Patients with Non-Breast/Gastroesophageal HER2-Amplified Tumors: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol J

Clinical cancer researchno. 7 (2024): 1273-1280

引用0浏览0WOS引用

加载更多

作者统计

#Papers: 72

#Citation: 944

H-Index: 16

G-Index: 30

Sociability: 6

Diversity: 2

Activity: 112

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn